Sep 21, 2026
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $999.00 to $4995.00.
The split itself did not change the total investment value.
KBIO LABS Inc. (KRX:038530) operates in the Medical distributors industry.
KBIO LABS Inc. company overviewKBIO LABS Inc.'s most recent stock split was on September 21, 2026. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
KBIO LABS Inc. (KRX:038530) has split its stock 5 times: a 858-for-817 split on May 4, 2005, a 1-for-10 reverse split on May 16, 2017, a 479-for-320 split on September 3, 2018, a 1-for-5 reverse split on May 12, 2026, and a 1-for-5 reverse split on September 21, 2026.
KBIO LABS Inc. has split its stock 5 times. This history records 5 splits between May 4, 2005 and September 21, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In KBIO LABS Inc.'s 1-for-5 reverse split on September 21, 2026, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
KBIO LABS Inc. has not announced a new split in our records. Its most recent split was on September 21, 2026, less than a year ago. Companies announce splits in advance, and any new KRX:038530 split will appear on this page.
Already premium?